Inventiva (IVA) Profit After Tax (2019 - 2025)
Inventiva (IVA) recorded quarterly Profit After Tax of -$2.3 million in Q2 2025, up 33.48% quarter-over-quarter from -$3.5 million in Q4 2024, and up 95.57% on a YoY basis from -$1.2 million in Q2 2024.
Inventiva (IVA) Profit After Tax (2019 - 2025) Analysis & Trends
Inventiva's Profit After Tax history runs 7 years deep, the most recent figure standing at -$2.3 million for Q2 2025.
- In Q2 2025, Profit After Tax rose 95.57% year-over-year to -$2.3 million; the TTM figure through Jun 2025 stood at -$2.3 million (up 97.96% YoY), while the FY2025 annual figure was -$412.2 million, down 109.42% from the prior year.
- Profit After Tax was -$2.3 million for Q2 2025 at Inventiva, up from -$3.5 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$945751.2 in Q4 2023 to a low of -$31.4 billion in Q2 2022.
- Historically, Profit After Tax has averaged -$3.2 billion across 5 years, with a median of -$21.8 million in 2021.
- The sharpest annual moves came in 2022 and 2023: Profit After Tax slumped 182529.0% in 2022, then soared 96.85% in 2023.
- A 5-year view of Profit After Tax shows it stood at -$26.5 million in 2021, then retreated by 13.59% to -$30.1 million in 2022, then jumped by 96.85% to -$945751.2 in 2023, then plunged by 272.07% to -$3.5 million in 2024, then jumped by 33.48% to -$2.3 million in 2025.
- The last three Profit After Tax figures came in at -$2.3 million (Q2 2025), -$3.5 million (Q4 2024), and -$52.8 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -56.74 Mn |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -2.34 Mn |
| Dec 31, 2024 | -3.52 Mn |
| Jun 30, 2024 | -52.80 Mn |
| Dec 31, 2023 | -945,751.18 |
| Dec 31, 2022 | -30.06 Mn |
| Sep 22, 2022 | -30.73 Mn |
| Jun 30, 2022 | -31.44 Bn |
| Dec 31, 2021 | -26.47 Mn |
| Jun 30, 2021 | -17.22 Mn |
| Mar 31, 2021 | -10.66 Mn |
| Dec 31, 2020 | -18.67 Mn |
| Jun 30, 2020 | -9.76 Mn |
| Mar 31, 2020 | -7.50 Mn |
| Dec 31, 2019 | -33.45 Mn |